A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer.

Trial Profile

A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2018

At a glance

  • Drugs Sipuleucel-T (Primary)
  • Indications Prostate cancer
  • Focus Adverse reactions
  • Acronyms PROCEED
  • Sponsors Dendreon Corporation
  • Most Recent Events

    • 05 Jun 2018 Results assessing the risk of CVEs presented at the 54th Annual Meeting of the American Society of Clinical Oncology
    • 05 Jun 2018 Results of a post-hoc analysis presented at the 54th Annual Meeting of the American Society of Clinical Oncology
    • 16 May 2017 Preliminary data from Proceed registry results presented at the 112th Annual Meeting of the American Urological Association
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top